CMV/EBV-specific T-cells (peptide-stimulated)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CMV/EBV-specific T-cells (peptide-stimulated), covering 2020-12-14 to 2020-12-14. Get the full timeline:
Most recent: Clinical Trial Update: Preventative/Preemptive Adoptive Transfer of Peptide Stimulated CMV/EBV Specific T-cells in Patients After Allogeneic Stem Cell Transplantation [Phase 1, Phase 2]